Home
Insights

Insights

Patent

From Generics to Biosimilars

Innovative medicinal products (also referred to as originator or reference products), whether chemical or biological, generally represent major therapeutic advances for patients. However, the high price of these products –…

Patent

THE DIVISIONAL GAME: HOW FAR CAN A PATENT STRATEGY GO?

462 million euros. That is the amount of the fine imposed by the European Commission on the pharmaceutical group Teva in October 2024, the largest ever handed down in a…

Trademark

Trademarks: a war of dates at the crossroads of legacy, heritage and deception

As consumers, we have all encountered brands claiming long-standing heritage for their products, whether genuine or not, suggesting an enduring market presence, a well-established tradition, or recognised craftsmanship. Yet, economic…

Patent

Patents and AI: when can an algorithm become patentable?

Artificial intelligence is everywhere. It analyses, predicts, optimises, recommends. But when a company develops a new AI algorithm, one question quickly arises: can it be protected by a patent? The…

Trademark

Tackling Bad Faith Trademark Registrations in China

In recent years, bad faith trademark registrations have occurred frequently in China and become a major challenge for brand owners. Although the China National Intellectual Property Administration (CNIPA) has implemented…

Trademark

Spotlight on Royal Warrants of Appointment and Official Suppliers to the British Crown

At the crossroads of royal traditions and commercial considerations, the Royal Warrant of Appointment enables a select group of beneficiaries to use the British Royal Arms in the course of…

Trademark

New accession to the international trademark system

The so-called “international” trademark system (also referred to as the “Madrid Agreement and Protocol system”) currently covers 132 countries, accounting for more than 80% of world trade. New members regularly…

Patent

From small molecules to biologics

The pharmaceutical industry has historically been driven by molecules obtained through chemical synthesis (so-called “small molecules”). From the 1990s onward, a new therapeutic era emerged with the advent of biological…

Patent

Case Note: The Strictness of the Confidentiality Regime before the UPC

The functioning of the Unified Patent Court (UPC) continues to become more refined through case law that now favours procedural certainty over subjective fairness. In a recent judgment delivered on…

Artisan travaillant le bois à l’atelier illustrant un savoir-faire traditionnel valorisable par une indication géographique

Indication Géographique • Geographical Indication

Geographical Indications for craft and industrial products: a new EU protection framework for regional know-how

Since 1 December 2025, the European Union has taken an important step forward in protecting regional know-how. A new system now makes it possible to register Geographical Indications (GIs) for…

Évolution de la part des actifs tangibles et intangibles dans la valeur de marché du S&P 500 de 1975 à 2020

Patent • Trademark • Audit PI

The predominant role of intangible assets in the modern economy

In a globalised and constantly evolving economic landscape, the very nature of value has undergone a radical transformation, marking the definitive transition from an industrial economy to an economy of…

Trademark • Designs

Brexit and “Cloned” Trademarks: Chronicle of a Turning Point on 1 January 2026

The end of the Brexit transition period on 1 January 2026 represents a decisive turning point for Brexit cloned trade marks. From that date, only genuine use in the United…

1 2 3 … 9 Page suivante

We value your privacy

We use cookies to make our site work properly and to give you a better browsing experience. With your consent, we may also use them to analyze site usage and show you content that matches your interests.

Customize

Cookies nécessaires

Cookies indispensables à la fourniture des services proposé sur le Site. Il est possible de les bloquer ou les supprimer en modifiant les paramètres navigateur (voir section dédiée), cependant, la suppression de ces cookies peut conduire à l’altération ou à la perte de certains réglages, et à rendre difficile la navigation.

Cookies d’analyse de site web

Cookies permettant la collecte d’informations qui sont utilisées afin d’enregistrer les statistiques des internautes sur les parcours. Ces cookies permettent de comptabiliser les visites sur le site et de déterminer les sources du trafic, en vue de son amélioration. Aucune donnée nominative n’est stockée. Aucune donnée statistique n’est regroupée avec des données nominatives que Santarelli pourrait détenir.

Cookies lecteur vidéo

Cookies permettant la lecture de vidéos. Aucune donnée nominative n’est stockée. Aucune donnée statistique n’est regroupée avec des données nominatives que Santarelli pourrait détenir. Attention la désactivation de ces cookies empêchera toutes lecture des vidéos.

Insights

Posts : Filtrer

From Generics to Biosimilars

THE DIVISIONAL GAME: HOW FAR CAN A PATENT STRATEGY GO?

Trademarks: a war of dates at the crossroads of legacy, heritage and deception

Patents and AI: when can an algorithm become patentable?

Tackling Bad Faith Trademark Registrations in China

Spotlight on Royal Warrants of Appointment and Official Suppliers to the British Crown

New accession to the international trademark system

From small molecules to biologics

Case Note: The Strictness of the Confidentiality Regime before the UPC

Geographical Indications for craft and industrial products: a new EU protection framework for regional know-how

The predominant role of intangible assets in the modern economy

Brexit and “Cloned” Trademarks: Chronicle of a Turning Point on 1 January 2026